We are live on ! Find out more
KKRC

Kohlberg Kravis Roberts & Co Portfolio holdings

AUM $5.35B
1-Year Est. Return 63.01%
This Fund
S&P 500
This Quarter Est. Return
+9.27%
1 Year Est. Return
+63.01%
3 Year Est. Return
+297.95%
5 Year Est. Return
+219.08%
10 Year Est. Return
+856.54%
AUM
$8.06B
AUM Growth
-$1.44B
Cap. Flow
-$1.96B
Cap. Flow %
-24.38%
Top 10 Hldgs %
90.93%
Holding
66
New
12
Increased
1
Reduced
6
Closed
9

Sector Composition

Rank Sector Weight
1 Healthcare 32.92%
2 Consumer Staples 24.42%
3 Technology 9.34%
4 Industrials 3.5%
5 Consumer Discretionary 0.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVTR
26
DELISTED
Nuvectra Corporation Common Stock
NVTR
$6.65M 0.08%
960,802
TMUSP
27
DELISTED
T-Mobile US, Inc.5.50% Mandatory Convertible Preferred Stock, Series A
TMUSP
$5.86M 0.07%
75,000
LH icon
28
Labcorp
LH
$25.2B
$5.79M 0.07%
+49,034
New +$5.78M
PFE icon
29
Pfizer
PFE
$143B
$4.81M 0.06%
+149,668
New +$5M
FDX icon
30
CALL
FedEx
FDX
$73B
$3.93M 0.05%
22,500
-4,500
-17% -$737K
AGN
31
DELISTED
Allergan plc
AGN
$3.8M 0.05%
+16,500
New +$4.03M
SPY icon
32
State Street SPDR S&P 500 ETF Trust
SPY
$771B
$3.79M 0.05%
+17,500
New +$3.78M
UTHR icon
33
United Therapeutics
UTHR
$26.1B
$3.25M 0.04%
+27,500
New +$3.3M
FTRPR
34
DELISTED
Frontier Communications Corporation 11.125% Series A Mandatory Convertible Preferred Stock
FTRPR
$2.94M 0.04%
35,000
-15,000
-30% -$1.39M
AET
35
DELISTED
Aetna Inc
AET
$2.69M 0.03%
+23,333
New +$2.73M
GHY
36
PGIM Global High Yield Fund
GHY
$476M
$2.12M 0.03%
140,253
HUM icon
37
Humana
HUM
$43.9B
$1.39M 0.02%
+7,833
New +$1.36M
DCUD
38
DELISTED
Dominion Energy, Inc 2016 Series A Corporate Units
DCUD
$998K 0.01%
+20,000
New +$1.02M
EAD
39
Allspring Income Opportunities Fund
EAD
$371M
$946K 0.01%
113,146
VTA
40
DELISTED
INVESCO DYNAMIC CREDIT OPPORTUNITIES FUND
VTA
$748K 0.01%
63,600
TBF icon
41
ProShares Short 20+ Year Treasury ETF
TBF
$87.2M
$735K 0.01%
35,000
JQC icon
42
Nuveen Credit Strategies Income Fund
JQC
$705M
$719K 0.01%
84,784
VRS
43
DELISTED
Verso Corporation
VRS
$65K ﹤0.01%
+10,023
New +$84.5K
KKR icon
44
KKR & Co
KKR
$89.1B
-4,667,166
Closed -$57.6M
TMO icon
45
Thermo Fisher Scientific
TMO
$214B
-58,139
Closed -$8.59M
TRP icon
46
TC Energy
TRP
$70.1B
-91,759
Closed -$4.15M
ZBH icon
47
Zimmer Biomet
ZBH
$18.8B
-3,877,765
Closed -$453M
PXD
48
DELISTED
Pioneer Natural Resource Co.
PXD
-10,990
Closed -$1.66M
RDS.B
49
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
-77,144
Closed -$4.32M
BKHU
50
DELISTED
Black Hills Corporation
BKHU
-297,753
Closed -$20.9M

Similar funds

Kohlberg Kravis Roberts & Co's Q3 2016 Portfolio in Review

As of Q3 2016, Kohlberg Kravis Roberts & Co held 66 positions worth $8.06B, down 15% from $9.49B the previous quarter. Its ten largest holdings account for 91% of the portfolio.

Kohlberg Kravis Roberts & Co withdrew a net $1.96B in Q3 2016, closing 9 positions and reducing 6 holdings. Its most notable exit was Zimmer Biomet, an estimated $453M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 47% a quarter earlier, followed by Consumer Staples and Technology.

Against the trend, Kohlberg Kravis Roberts & Co opened a new position in Crown Castle International Corp. worth $219M.

  • Kohlberg Kravis Roberts & Co's largest Q3 2016 buy was Crown Castle International Corp.: 1,941,459 shares worth $219M.
  • Kohlberg Kravis Roberts & Co's biggest Q3 2016 reduction was Walgreens Boots Alliance, cutting an estimated $1.19B.
  • Kohlberg Kravis Roberts & Co fully exited Zimmer Biomet in Q3 2016, selling an estimated $453M.
  • Kohlberg Kravis Roberts & Co's ten largest holdings make up 91% of its $8.06B portfolio in Q3 2016.
  • Kohlberg Kravis Roberts & Co opened 12 new positions and closed 9 in Q3 2016.
  • Kohlberg Kravis Roberts & Co's portfolio value fell 15% quarter-over-quarter to $8.06B.

Based on Kohlberg Kravis Roberts & Co's 13F filing for Q3 2016, filed 14 Nov 2016.